Table 1 Patient characteristics.

From: MUC1 ectodomain is a flagellin-targeting decoy receptor and biomarker operative during Pseudomonas aeruginosa lung infection

VAP Patients

P. aeruginosa (n = 13)

Other microorganisms (n = 32)a or culture-negative (n = 16)

p Value

Age in years, mean S.D

61.8 ± 9.8

58.6 ± 12.7

0.42

BMI, mean S.D

32.1 ± 11.9

31.3 ± 10.6

0.81

Ventilator-free days, mean S.D

8.2 ± 11.3

18.7 ± 10.0

0.002

APACHE II Score, mean ± S.D

17.7 ± 7.0

18.6 ± 8.7

0.72

Race, n

   

White

7 (53.8%)

27 (56.2%)

0.88

African American

6 (46.2%)

18 (37.5%)

0.58

Other

0 (0.0%)

3 (6.3%)

0.36

Gender, n

   

Male

4 (30.8%)

24 (50.0%)

0.22

Female

9 (69.2%)

24 (50.0%)

0.22

ICU Locationm, n

   

Acute Care MICU

5 (38.5%)

39 (81.2%)

0.002

Acute Care CCRU

0 (0.0%)

3 (6.3%)

0.36

Long-Term CPRU

8 (61.5%)

6 (12.5%)

 < 0.001

Antibiotics, n

13 (100%)

46 (96.0%)

0.45

Anti-Pseudomonal Antibiotics

13 (100%)

39 (81.3%)

0.11

Chest X-ray Abnormality, n

13 (100%)

46 (96.0%)

0.45

  1. aAspergillus spp. (n = 1), Candida spp. (n = 2), Candida albicans (n = 5), Candida parapsilosis (n = 1), Enterococcus spp. (n = 4), Escherichia coli (n = 1), Klebsiella oxytoca (n = 1), Klebsiella pneumoniae (n = 1), Lactobacillus spp. (n = 1), Mycobacterium chelonae (n = 1), normal respiratory flora (n = 4), Proteus mirabilis (n = 1), Rothia spp. (n = 1), Staphylococcus spp. (n = 3), Staphylococcus aureus (n = 1), Streptococcus spp. (n = 6), Streptococcus pyogenes (n = 1).
Back to article page